Apr 29, 2026
Why AstraZeneca (AZN) Stock Fell Despite Crushing Q1 Earnings Expectations
AstraZeneca (AZN) shares dip despite beating Q1 forecasts with $15.29B revenue. Analysts say strong results were already baked into the stock price.
The post Why AstraZeneca (AZN) Stock Fell Despite Crushing Q1 Earnings Expectations appeared first on Blockonomi.
Source: Blockonomi →Related News
- 16 hours ago
Hewlett Packard Enterprise (HPE) Stock Soars to Record Peak as Elliott Expands P...
- 16 hours ago
Norwegian Cruise Line (NCLH) Stock Plummets 9.5% — Company Insiders Buy Big
- 16 hours ago
Dell (DELL) Stock Rockets 16% to All-Time Peak Ahead of May 28 Earnings
- 16 hours ago
BlackBerry (BB) Stock Surges 19% to New 52-Week Peak on Bullish Outlook
- 16 hours ago
Navitas Semiconductor (NVTS) Stock Soars 20% as AI Power Shift Fuels Rally